(Q43975472)

28 November 2017

title

Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size (English)

1 reference

28 November 2017

Baldini M

1

1 reference

28 November 2017

Gallazzi M

2

1 reference

28 November 2017

Orsatti A

3

1 reference

28 November 2017

Fossati S

4

1 reference

28 November 2017

Leonardi P

5

1 reference

28 November 2017

Cantalamessa L

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of Internal Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

251

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

407-414

1 reference

Changing concepts in the diagnosis and management of thyroid nodules

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Thyroxine suppressive therapy in patients with nodular thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Hyperthyroidism, thyroid hormone therapy, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Subclinical thyroid dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

The effect of thyroid hormone on skeletal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Direct stimulation of bone resorption by thyroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3'-triiodo-L-thyronine nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

L-thyroxine dosage: a reevaluation of therapy with contemporary preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Bone mineral density and thyroid hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Levothyroxine therapy in patients with thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Applications of a new chemiluminometric thyrotropin assay to subnormal measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00977.X

10.1046/J.1365-2796.2002.00977.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference